Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $2.21 USD
Change Today +0.15 / 7.28%
Volume 1.2M
SNTA On Other Exchanges
Symbol
Exchange
NASDAQ GM
Stuttgart
As of 5:20 PM 07/28/15 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - synta pharmaceuticals corp (SNTA)

Name (Connections)Board RelationshipsTitleKey Developments
Keith Gollust 46 RelationshipsExecutive Chairman, Chairman of Nominating & Governance Committee, Chairman of Executive Committee, Member of Audit Committee and Member of Compensation CommitteeSynta Pharmaceuticals Corp. announced delayed annual 10-K filing
03/17/09
Robert Wilson 65 RelationshipsDirector, Chairman of Compensation Committee, Member of Executive Committee and Member of Audit Committee 
William Reardon CPA 53 RelationshipsDirector and Chairman of Audit Committee 

Compensation Committee* - synta pharmaceuticals corp (SNTA)

Name (Connections)Board RelationshipsTitle
Paul Friedman M.D. 73 RelationshipsDirector, Member of Executive Committee and Member of Compensation Committee
Keith Gollust 46 RelationshipsExecutive Chairman, Chairman of Nominating & Governance Committee, Chairman of Executive Committee, Member of Audit Committee and Member of Compensation Committee
Bruce Kovner 162 RelationshipsDirector, Member of Compensation Committee and Member of Nominating & Governance Committee
Robert Wilson 65 RelationshipsDirector, Chairman of Compensation Committee, Member of Executive Committee and Member of Audit Committee
SNTA Compensation vs. Industry
27.5K
360.8K
Chief Executive Officer
21.0K
263.3K
Chief Financial Officer
Share price activity for SYNTA PHARMACEUTICALS CORP (SNTA)
52 Week Price Performance
SNTA
Industry Average

Nominating Committee* - synta pharmaceuticals corp (SNTA)

Name (Connections)Board RelationshipsTitleKey Developments
Keith Gollust 46 RelationshipsExecutive Chairman, Chairman of Nominating & Governance Committee, Chairman of Executive Committee, Member of Audit Committee and Member of Compensation CommitteeSynta Pharmaceuticals Corp. Announces Executive Changes
04/27/15
Bruce Kovner 162 RelationshipsDirector, Member of Compensation Committee and Member of Nominating & Governance CommitteeSynta Pharmaceuticals Corp. Announces Executive Changes
12/4/14
Donald Kufe M.D. 21 RelationshipsDirector and Member of Nominating & Governance CommitteeSynta Pharmaceuticals Corp. Appoints Anne Whitaker as President, Chief Executive Officer and Member of the Board of Directors, Effective from September 2, 2014
08/6/14

Corporate Governance Committee* - synta pharmaceuticals corp (SNTA)

Name (Connections)Board RelationshipsTitle
Keith Gollust 46 RelationshipsDirector, Member of Executive Committee and Member of Compensation Committee
Bruce Kovner 162 RelationshipsExecutive Chairman, Chairman of Nominating & Governance Committee, Chairman of Executive Committee, Member of Audit Committee and Member of Compensation Committee
Donald Kufe M.D. 21 RelationshipsDirector, Member of Compensation Committee and Member of Nominating & Governance Committee
SNTA and Competitor
Insiders vs. External
Board
13%
87%
Synta Pharmaceuticals Corp.
Insiders
External Board Members

Executive Committee* - synta pharmaceuticals corp (SNTA)

Name (Connections)Board RelationshipsTitle
Paul Friedman M.D. 73 RelationshipsDirector, Member of Executive Committee and Member of Compensation Committee
Keith Gollust 46 RelationshipsExecutive Chairman, Chairman of Nominating & Governance Committee, Chairman of Executive Committee, Member of Audit Committee and Member of Compensation Committee
Robert Wilson 65 RelationshipsDirector, Chairman of Compensation Committee, Member of Executive Committee and Member of Audit Committee
Management Effectiveness Relative to the Industry
Return on Equity
NM
Return on Assets
0.7x
Return on Total Capital
NM
TEV/Total Revenue(LTM)
NM

Advisory Committee* - synta pharmaceuticals corp (SNTA)

Name (Board Relationships)/Title Board Affiliations
James Black 14 Relationships
Member of Scientific Advisory Board
No other board affiliations
Marc Garnick 85 Relationships
Member of Scientific Advisory Board
No other board affiliations
Nir Hacohen 14 Relationships
Member of Scientific Advisory Board
No other board affiliations
Jean-Pierre Kinet 18 Relationships
Member of Scientific Advisory Board
No other board affiliations
Christopher Logothetis 25 Relationships
Member of Scientific Advisory Board
No other board affiliations
Daniel Von Hoff 559 Relationships
Member of Scientific Advisory Board
No other board affiliations
Bruce Zetter 73 Relationships
Member of Scientific Advisory Board
No other board affiliations
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SNTA:US $2.21 USD +0.15

SNTA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for SNTA.
View Industry Companies
 

Industry Analysis

SNTA

Industry Average

Valuation SNTA Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 4.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SYNTA PHARMACEUTICALS CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.